Page last updated: 2024-08-23

azoxymethane and Abnormalities, Autosome

azoxymethane has been researched along with Abnormalities, Autosome in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Furuta, M; Ikezumi, M; Izumi, K; Kawakami, K; Matsumoto, H; Negishi, S; Ohta, R; Sasaki, K; Sui, H; Takahashi, T; Takashi, K; Todoriki, S; Toyoizumi, T; Yamakage, K	1
Bifulco, M; Borrelli, F; Gazzerro, P; Grimaldi, C; Izzo, AA; Laezza, C; Malfitano, AM; Pisanti, S; Proto, MC; Santoro, A	1

Other Studies

2 other study(ies) available for azoxymethane and Abnormalities, Autosome

Article	Year
Genotoxic potential and in vitro tumour-promoting potential of 2-dodecylcyclobutanone and 2-tetradecylcyclobutanone, two radiolytic products of fatty acids. Mutation research. Genetic toxicology and environmental mutagenesis, 2014, Volume: 770 Topics: Animals; Azoxymethane; Carcinogens; Cell Line; Chromosome Aberrations; Colon; Comet Assay; Cricetinae; Cyclobutanes; DNA Damage; Dose-Response Relationship, Drug; Fatty Acids; Female; Food Irradiation; Male; Mice; Mice, Inbred ICR; Micronucleus Tests; Mutagenicity Tests; Mutagens; Neoplasms; Rats; Rats, Sprague-Dawley; Salmonella typhimurium	2014
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon. International journal of cancer, 2009, Sep-01, Volume: 125, Issue:5 Topics: Animals; Apoptosis; Aurora Kinase B; Aurora Kinases; Azoxymethane; Blotting, Western; Cannabinoid Receptor Antagonists; Cell Cycle; Cell Proliferation; Checkpoint Kinase 1; Chromosome Aberrations; Colony-Forming Units Assay; Colorectal Neoplasms; Cyclin B; Cyclin B1; DNA Damage; Female; Humans; Mice; Mice, Inbred C57BL; Mitotic Index; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Piperidines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Polyploidy; Precancerous Conditions; Protein Kinases; Protein Serine-Threonine Kinases; Pyrazoles; Rimonabant; Tumor Cells, Cultured	2009

Article

Year

Genotoxic potential and in vitro tumour-promoting potential of 2-dodecylcyclobutanone and 2-tetradecylcyclobutanone, two radiolytic products of fatty acids.

Mutation research. Genetic toxicology and environmental mutagenesis, 2014, Volume: 770

Topics: Animals; Azoxymethane; Carcinogens; Cell Line; Chromosome Aberrations; Colon; Comet Assay; Cricetinae; Cyclobutanes; DNA Damage; Dose-Response Relationship, Drug; Fatty Acids; Female; Food Irradiation; Male; Mice; Mice, Inbred ICR; Micronucleus Tests; Mutagenicity Tests; Mutagens; Neoplasms; Rats; Rats, Sprague-Dawley; Salmonella typhimurium

2014

Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon.

International journal of cancer, 2009, Sep-01, Volume: 125, Issue:5

Topics: Animals; Apoptosis; Aurora Kinase B; Aurora Kinases; Azoxymethane; Blotting, Western; Cannabinoid Receptor Antagonists; Cell Cycle; Cell Proliferation; Checkpoint Kinase 1; Chromosome Aberrations; Colony-Forming Units Assay; Colorectal Neoplasms; Cyclin B; Cyclin B1; DNA Damage; Female; Humans; Mice; Mice, Inbred C57BL; Mitotic Index; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Piperidines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Polyploidy; Precancerous Conditions; Protein Kinases; Protein Serine-Threonine Kinases; Pyrazoles; Rimonabant; Tumor Cells, Cultured

2009